Core Laboratories (NYSE: CLB) ended 2016 on a high note, delivering expectation-beating earnings after its highly anticipated recovery finally started to take hold. However, the company did warn that the recovery would take a slight breather during the first quarter as seasonal and tax headwinds would hold back growth. Given those expectations, here are a few things investors should watch when Core Labs reports earnings later this week.